Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


JDSC jumps to series B funding
Utec was among the backers that helped University of Tokyo spinout Japan Data Science Consortium complete a $27.5m round.
Disarm hands itself to Eli Lilly
Eli Lilly will acquire the WUSTL-linked neurological disease therapy developer in a $135m deal that could top $1.2bn with milestone payments.
Nanofilm rolls towards stock market
NTU spinout Nanofilm Technologies has seemingly filed a draft prospectus with a view of listing on the domestic Singapore Stock Exchange.
Codiak Biosciences cracks IPO code
Codiak – based on research at Gothenburg and MD Anderson Cancer Center – has succeeded in going public after previously cancelling plans.
TIAP absorbs state funding
The federal development board for Southern Ontario has injected $5m to accelerate the growth potential of TIAP's early-stage health sciences portfolio.
Pingue plugs into CDP’s tech transfer fund
Claudia Pingue, former Politecnico di Milano tech transfer manager, has taken on a leadership role at CDP's $177m spinout investment fund.
Daily deal net: October 9, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Gamma Biosciences absorbs Nanopareil
Nanopareil employs nanofibre membranes to separate chemical compounds for the purposes of purifying biopharmaceutical candidates.

Other News

UNC-Chapel Hill celebrates commercialisation impact
Five-year commercialisation activity at the university is on the rise in terms of patents, inventions and licensing revenue.
Will Ventures locks down $50m fund
University endowment-backed Will Ventures aims to unlock sports-related innovation across markets such as fitness, media and gaming.
Momentus finds Stable Road to Nasdaq
University of Wyoming-backed Momentus is set to merge with SPAC Stable Road Acquisition in a deal that values the space infrastructure company at $1.2bn.
Daily deal net: October 7, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Kronos Bio casts IPO range
MIT's cancer therapy developer has set terms for an offering that will raise more than $185m if it floats at the top of its range.
Readcoor agrees to $350m acquisition
10x Genomics has bought Harvard's genetic sequencing system provider and also revealed it closed its purchase of Stockholm University spinout CartaNA.

Editor's Picks

SETsquared: a global leader continues charging ahead
The world’s number one incubator has been making a big impact since 2002, having supported more than 4,000 entrepreneurs that have raised more than $2.2bn between them.
It’s not about the money
Lessons from the GUV Summit in Houston, Texas, this month
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
UCL Technology Fund: an unparalleled approach to commercialisation
Editor Thierry Heles sits down with David Grimm (pictured), manager of the UCL Technology Fund, to find out what makes the fund unique among its UK and international peers.
test reg